124 related articles for article (PubMed ID: 7586059)
1. Structure-activity relationships of neuromedin U. II. Highly potent analogs substituted or modified at the N-terminus of neuromedin U-8.
Hashimoto T; Kurosawa K; Sakura N
Chem Pharm Bull (Tokyo); 1995 Jul; 43(7):1154-7. PubMed ID: 7586059
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of neuromedin U. I. Contractile activity of dog neuromedin U-related peptides on isolated chicken crop smooth muscle.
Sakura N; Kurosawa K; Hashimoto T
Chem Pharm Bull (Tokyo); 1995 Jul; 43(7):1148-53. PubMed ID: 7586058
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of neuromedin U. III. Contribution of two phenylalanine residues in dog neuromedin U-8 to the contractile activity.
Kurosawa K; Sakura N; Hashimoto T
Chem Pharm Bull (Tokyo); 1996 Oct; 44(10):1880-4. PubMed ID: 8904815
[TBL] [Abstract][Full Text] [Related]
4. Contractile activity of porcine neuromedin U-25 and various neuromedin U-related peptide fragments on isolated chicken crop smooth muscle.
Okimura K; Sakura N; Ohta S; Kurosawa K; Hashimoto T
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1500-3. PubMed ID: 1394668
[TBL] [Abstract][Full Text] [Related]
5. Agonistic and antagonistic activities of neuromedin U-8 analogs substituted with glycine or D-amino acid on contractile activity of chicken crop smooth muscle preparations.
Hashimoto T; Masui H; Uchida Y; Sakura N; Okimura K
Chem Pharm Bull (Tokyo); 1991 Sep; 39(9):2319-22. PubMed ID: 1804545
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of neuromedin U. IV. Absolute requirement of the arginine residue at position 7 of dog neuromedin U-8 for contractile activity.
Sakura N; Kurosawa K; Hashimoto T
Chem Pharm Bull (Tokyo); 2000 Aug; 48(8):1166-70. PubMed ID: 10959581
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of rat neuromedin U for smooth muscle contraction.
Sakura N; Ohta S; Uchida Y; Kurosawa K; Okimura K; Hashimoto T
Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2016-20. PubMed ID: 1797423
[TBL] [Abstract][Full Text] [Related]
8. Development of potent and proteolytically stable human neuromedin U receptor agonists.
De Prins A; Martin C; Van Wanseele Y; Skov LJ; Tömböly C; Tourwé D; Caveliers V; Van Eeckhaut A; Holst B; Rosenkilde MM; Smolders I; Ballet S
Eur J Med Chem; 2018 Jan; 144():887-897. PubMed ID: 29329072
[TBL] [Abstract][Full Text] [Related]
9. Primary structure and pharmacological activity of a nonapeptide related to neuromedin U isolated from chicken intestine.
O'Harte F; Bockman CS; Zeng W; Abel PW; Harvey S; Conlon JM
Peptides; 1991; 12(4):809-12. PubMed ID: 1788145
[TBL] [Abstract][Full Text] [Related]
10. Characterization of neuromedin U effects in canine smooth muscle.
Westfall TD; McCafferty GP; Pullen M; Gruver S; Sulpizio AC; Aiyar VN; Disa J; Contino LC; Mannan IJ; Hieble JP
J Pharmacol Exp Ther; 2002 Jun; 301(3):987-92. PubMed ID: 12023529
[TBL] [Abstract][Full Text] [Related]
11. Isolation, structural characterization and pharmacological activity of dog neuromedin U.
O'Harte F; Bockman CS; Abel PW; Conlon JM
Peptides; 1991; 12(1):11-5. PubMed ID: 2052487
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel lipidated neuromedin U analogs with increased stability and effects on food intake.
Dalbøge LS; Pedersen SL; van Witteloostuijn SB; Rasmussen JE; Rigbolt KT; Jensen KJ; Holst B; Vrang N; Jelsing J
J Pept Sci; 2015 Feb; 21(2):85-94. PubMed ID: 25521062
[TBL] [Abstract][Full Text] [Related]
13. Species-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice.
Prendergast CE; Morton MF; Figueroa KW; Wu X; Shankley NP
Br J Pharmacol; 2006 Apr; 147(8):886-96. PubMed ID: 16474416
[TBL] [Abstract][Full Text] [Related]
14. The motor effect of neuromedin U on rat stomach in vitro.
Benito-Orfila MA; Domin J; Nandha KA; Bloom SR
Eur J Pharmacol; 1991 Feb; 193(3):329-33. PubMed ID: 2055247
[TBL] [Abstract][Full Text] [Related]
15. Isolation, structural characterization, and bioactivity of a novel neuromedin U analog from the defensive skin secretion of the Australasian tree frog, Litoria caerulea.
Salmon AL; Johnsen AH; Bienert M; McMurray G; Nandha KA; Bloom SR; Shaw C
J Biol Chem; 2000 Feb; 275(7):4549-54. PubMed ID: 10671478
[TBL] [Abstract][Full Text] [Related]
16. A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects.
Inooka H; Sakamoto K; Shinohara T; Masuda Y; Terada M; Kumano S; Yokoyama K; Noguchi J; Nishizawa N; Kamiguchi H; Fujita H; Asami T; Takekawa S; Ohtaki T
Bioorg Med Chem; 2017 Apr; 25(8):2307-2312. PubMed ID: 28291683
[TBL] [Abstract][Full Text] [Related]
17. Neuromedin U: a multifunctional neuropeptide with pleiotropic roles.
Martinez VG; O'Driscoll L
Clin Chem; 2015 Mar; 61(3):471-82. PubMed ID: 25605682
[TBL] [Abstract][Full Text] [Related]
18. Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.
Mitchell JD; Maguire JJ; Davenport AP
Br J Pharmacol; 2009 Sep; 158(1):87-103. PubMed ID: 19519756
[TBL] [Abstract][Full Text] [Related]
19. Neuromedin U stimulates contraction of human long saphenous vein and gastrointestinal smooth muscle in vitro.
Jones NA; Morton MF; Prendergast CE; Powell GL; Shankley NP; Hollingsworth SJ
Regul Pept; 2006 Sep; 136(1-3):109-16. PubMed ID: 16782214
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical behavior of neuromedin U in isolated smooth muscle cells and intact tissue.
Brighton PJ; Wise A; Dass NB; Willars GB
J Pharmacol Exp Ther; 2008 Apr; 325(1):154-64. PubMed ID: 18180374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
